The Oncology Institute (NASDAQ: TOI)
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-11-04 | ||||||
REV |
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.060 | ||||||
REV | 60.921M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of The Oncology Institute (NASDAQ: TOI) through any online brokerage.
Other companies in The Oncology Institute’s space includes: Cano Health (NYSE:CANO), Universal Health Services (NYSE:UHS), Encompass Health (NYSE:EHC), Acadia Healthcare Co (NASDAQ:ACHC) and HCA Healthcare (NYSE:HCA).
The latest price target for The Oncology Institute (NASDAQ: TOI) was reported by Jefferies on Monday, August 15, 2022. The analyst firm set a price target for 10.00 expecting TOI to rise to within 12 months (a possible 46.63% upside). 1 analyst firms have reported ratings in the last year.
The stock price for The Oncology Institute (NASDAQ: TOI) is $6.82 last updated August 17, 2022, 8:00 PM UTC.
There are no upcoming dividends for The Oncology Institute.
The Oncology Institute’s Q3 earnings are confirmed for Friday, November 4, 2022.
There is no upcoming split for The Oncology Institute.
The Oncology Institute is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.